Min Li

Dr. Min Li


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2023 in International Journal of Oncology
Verified
Journal Article
Open access
PDF file
CSChiyun Shao
Chiyun Shao
YHYanjie Han
Yanjie Han
YHYuying Huang
Yuying Huang
ZZZhe Zhang
Zhe Zhang
TGTao Gong
Tao Gong
MLMin Li
Min Li
RNA methylation modifications are closely linked to tumor development, migration, invasion and responses to various therapies. Recent studies have shown notable advancements regarding the roles of RNA methylation in tumor immunotherapy, the tumor microenvironment and metabolic reprogramming. However, research on the association between tumor chemoresistance and N6‑methyladenosine (m6A) methyltransferases in specific cancer types is still scarce. Colorectal cancer (CRC) is among the most common gastrointestinal cancers worldwide. Conventional chemotherapy remains the predominant treatment modality for CRC and chemotherapy resistance is the primary cause of treatment failure. The expression levels of m6A methyltransferases, including methyltransferase‑like 3 (METTL3), METTL14 and METTL16, in CRC tissue samples are associated with patients' clinical outcomes and chemotherapy efficacy. Natural pharmaceutical ingredients, such as quercetin, have the potential to act as METTL3 inhibitors to combat chemotherapy resistance in patients with CRC. The present review discussed the various roles of different types of key RNA methylation enzymes in the development of CRC, focusing on the mechanisms associated with chemotherapy resistance. The progress in the development of certain inhibitors is also listed. The potential of using natural remedies to develop antitumor medications that target m6A methylation is also outlined.

8 March 2024 in Biochemical Pharmacology
Verified
Journal Article
Closed access
ZZZhengguang Zhang
Zhengguang Zhang
TLTianming Lu
Tianming Lu
ZZZhe Zhang
Zhe Zhang
ZLZixian Liu
Zixian Liu
RQRuoning Qian
Ruoning Qian
MLMin Li
Min Li

10 January 2025 in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Verified
Journal Article
Closed access
ZZZhengguang Zhang
Zhengguang Zhang
HWHaitao Wu
Haitao Wu
MLMin Li
Min Li
FZFuqiong Zhou
Fuqiong Zhou
LGLulu Gao
Lulu Gao

17 December 2024 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
ZZZhengguang Zhang
Zhengguang Zhang
ZLZixian Liu
Zixian Liu
YYYing Yao
Ying Yao
MLMin Li
Min Li
CSCunsi Shen
Cunsi Shen
FZFuqiong Zhou
Fuqiong Zhou

6 December 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
HDHaina Du
Haina Du
DXDachao Xu
Dachao Xu
SZShuhui Zhang
Shuhui Zhang
XZXinliang Zhang
Xinliang Zhang
MFMingzhi Fang
Mingzhi Fang
MLMin Li
Min Li
Enterogenous cyst (EC) is a rare congenital lesion generally located in the central nervous system, such as in the cerebral hemispheres, posterior fossa, or spinal canal. They are usually benign lesions, and malignant transformation is rare. A 42-year-old woman felt an obvious pain in the lump and went to a local hospital for local lumpectomy. After 7 months, she again felt pain in the buttocks and difficulty in urinating and defecation. The computed tomography (CT) scan showed a mass in the pelvis. Sacrococcygeal cyst excision was performed 10 days later, and postoperative pathology showed epidermoid cyst. Shortly after, the patient recovered and was discharged from the hospital; the pain in the buttocks continued to recur. Puncture and drainage were performed five times. Later, the patient went to our hospital for treatment, and pelvic MRI showed multiple abnormal signal shadows in the presacral and sacrococcygeal regions, some of which were considered abscesses, and some were cystic lesions. She underwent tumor resection and was diagnosed with EC with locally moderately differentiated adenocarcinoma. Four months later, the patient’s symptoms of swelling and pain recurred. MRI examination showed multiple high-signal T2 shadows in the anterior sacral and subcutaneous tissues of the buttocks, and enhanced scan showed partial marginal enhancement. After assessment, the patient was given a radiation dose of 60 Gy/25F. ECs in the anterior sacral and soft tissue of the buttocks are very rare, and the case of carcinomatous transformation has never been reported. Therefore, we discussed the clinicopathological features of ectopic ECs and reviewed the literature.

13 January 2026 in Redox Biology
Verified
Journal Article
Open access
QLQian Liu
Qian Liu
BLBinliang Liu
Binliang Liu
ZLZhenbao Liu
Zhenbao Liu
LGLidan Gong
Lidan Gong
MLMin Li
Min Li
XLXiangjian Luo
Xiangjian Luo
Epstein-Barr virus (EBV)-associated carcinomas exhibit reprogrammed redox metabolism, yet the underlying regulatory network and potential metabolic vulnerabilities remain incompletely defined. Here we identify a viral-host transcriptional axis in which EBV EBNA1 induces the transcription factor FOSL2 to repress ALDH3A1. Restoration of ALDH3A1 in EBV-positive models disrupts NAD(P)H/NAD(P)+ homeostasis, inducing reductive stress. This reductive milieu upregulates GSNOR and TrxR1, potentiating the denitrosylation of GSK3β, leading to its stabilization and suppression of the Wnt/β-catenin pathway. We establish that S-nitrosylation at GSK3β Cys199 controls its stability, providing a mechanistic bridge from redox regulation to Wnt inhibition. Critically, ALDH3A1 elevation selectively curbs EBV-positive tumor growth, exploiting an infection-specific vulnerability in redox signaling. Thus, our findings integrate EBV-driven redox remodeling with Wnt/β-catenin signaling activation and propose ALDH3A1 induction as a promising therapeutic strategy for EBV-associated carcinomas.